Goldline Pharmaceutical IPO Subscription Status
Goldline Pharmaceutical IPO subscription started on 12 May, 2026 and will close on 14 May, 2026. The retail quota is 33.33%, QIB is 47.11% and NII is 14.44%. Goldline Pharmaceutical IPO got a lot of interest, raising around ₹27,00,000 shares (agg. up to ₹12 Cr) Crores, with subscriptions 840.74 times overall, including 180.22 times by institutional investors, 1662.04 times by non-institutional investors, and 881.15 times by retail investors. Shares are priced between ₹₹41 to ₹43 per share each and will be listed on the BSE.
Last Updated - May 14, 2026 11:55 pm
|
Check Live IPO Subscription List 👈
|
| Listed |
Goldline Pharmaceutical IPO Subscription - Day 3
| QIB - Qualified Institutional Buyers: | 180.22x |
| NII - Non-Institutional Investors: | 1662.04x |
| SNII - Small Non-Institutional Investors: | [.]x |
| BNII - Big Non-Institutional Investors: | [.]x |
| RII - Retail Individual Investor: | 881.15x |
| Total: | 840.74x 👈 |
Goldline Pharmaceutical IPO Investor Categories
- Qualified Institutional Buyers: QIB
- Non-Institutional Investors: NII
- Small Non-Institutional Investors: SNII- Bid below ₹10L
- Big Non-Institutional Investors: BNII- Bid above ₹10L
- Retail Individual Investor: RII
- Employees Quota: EMP
Goldline Pharmaceutical IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 12 May, 2026 |
| Close Date: | 14 May, 2026 |
| Allotment Date: | 15 May, 2026 |
| Refund Date: | 18 May, 2026 |
| Shares Credit Date: | 18 May, 2026 |
| Listing Date: | 19 May, 2026 |
Goldline Pharmaceutical IPO Subscription Status FAQs
Q.When Goldline Pharmaceutical IPO Subscription will start?
Ans.The IPO subscription starts on 12 May, 2026 for Investors.
Q.What is the Goldline Pharmaceutical IPO Subscription last date?
Ans.Goldline Pharmaceutical IPO subscription last date is 14 May, 2026 for Investors.
Q.What is the Goldline Pharmaceutical IPO Allotment Date?
Ans.Goldline Pharmaceutical IPO allotment date is 15 May, 2026.
Q.What is the Goldline Pharmaceutical IPO Listing Date?
Ans.Goldline Pharmaceutical IPO listing date is 19 May, 2026. The IPO is to list on BSE.